2081 - COVID-19 mRNA Vaccine Effectiveness against Hospitalizations among U.S. Children and Adolescents During Omicron Variant Predominance

Presenting Author(s)

• 

  Laura D. Zambrano, PhD, MPH (she/her/hers)

  Senior Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, GA, United States

  Slides

Co-Author(s)

• MN

  Margaret M. Newhams, MPH

  Project Manager
  Boston Children's Hospital
  Boston, Massachusetts, United States
• MW

  Michael J. Wu, MSc

  Centers for Disease Control and Prevention
  Atlanta, Georgia, United States
• 

  Regina Simeone, PhD (she/her/hers)

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, Georgia, United States
• AO

  Amber Orzel, MPH

  Boston Children's Hospital
  Boston, Massachusetts, United States
• 

  Natasha B. Halasa, MD, MPH (she/her/hers)

  Craig Weaver Professor of Pediatrics
  Vanderbilt University Medical Center
  Nashville, TN, United States
• KF

  Katherine E. Fleming-Dutra, MD

  Medical Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, Georgia, United States
• 

  Angela P. Campbell, MD, MPH, FPIDS, FIDSA

  Medical Officer
  Centers for Disease Control and Prevention
  Atlanta, GA, United States
• AR

  Adrienne G. Randolph, MD, MSc

  Boston Children's Hospital, Harvard Medical School
  Boston, Massachusetts, United States